NCT01803113View on ClinicalTrials.gov

Sofia hCG FIA Field Study

CompletedOBSERVATIONAL
Enrollment

975

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Pregnancy, Early Detection
Interventions
DEVICE

Sofia hCG FIA

Qualitative detection via immunofluorescence technology of increased level of hCG present in urine.

Trial Locations (5)

77023

Planned Parenthood Gulf Coast, Houston

33435-7959

Jose Castaneda, MD, Boynton Beach

02720

NECCR of Massachusetts, LLC, Fall River

New England Center for Clinical Research Fall River,LLC (NECCR), Fall River

02860

Partners In Obstetrics and Gynecology, Inc., Pawtucket

All Listed Sponsors
lead

Quidel Corporation

INDUSTRY

NCT01803113 - Sofia hCG FIA Field Study | Biotech Hunter | Biotech Hunter